Cargando…
Statins and PCSK9 inhibitors: What is their role in coronavirus disease 2019?
Statins and proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors interfere with several pathophysiological pathways of coronavirus disease 2019 (COVID-19). Statins may have a direct antiviral effect on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by inhibiting its main pr...
Autores principales: | Barkas, Fotios, Milionis, Haralampos, Anastasiou, Georgia, Liberopoulos, Evangelos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724447/ https://www.ncbi.nlm.nih.gov/pubmed/33333472 http://dx.doi.org/10.1016/j.mehy.2020.110452 |
Ejemplares similares
-
Sodium-glucose cotransporter inhibitors may reduce the risk of pneumonia: an updated meta-analysis of cardiovascular outcome trials
por: Barkas, Fotios, et al.
Publicado: (2021) -
Bradycardia and coronavirus disease 2019: What is behind?
por: Barkas, Fotios, et al.
Publicado: (2021) -
Anakinra in COVID-19: A step closer to the cure
por: Barkas, Fotios, et al.
Publicado: (2022) -
A step-by-step guide for the diagnosis and management of hyponatraemia in
patients with stroke
por: Barkas, Fotios, et al.
Publicado: (2023) -
Sinus Bradycardia Associated with Remdesivir Treatment in COVID-19: A Case Report and Literature Review
por: Barkas, Fotios, et al.
Publicado: (2021)